Farmacie pro praxi. 2023;19(3):e4-e9 [Psychiatr. praxi. 2023;24(2):70-75]
Serious states induced by taking psychopharmacs and their treatment
- Eva Češková1, 2, 3, Kateřina Horská4, 5
- 1
Psychiatrická klinika LF MU a FN Brno
- 2
KPN LF Ostravská univerzita
- 3
Oddělení psychiatrie, FN Ostrava
- 4
Úsek klinické farmacie, Nemocniční lékárna, Fakultní nemocnice Brno
- 5
Ústav farmakologie a toxikologie, Farmaceutická fakulta, Masarykova univerzita, Brno
The article summarizes current knowledge of severe states associated with taking antidepressants and antipsychotics. These states usually require immediate intervention and include acute and tardive dystonia, tardive dyskinesias, neuroleptic malignant syndrome, serotonin syndrome and withdrawal-induced syndrome. Regarding their severity, and sometimes unexpectedly manifestation, they represent severe adverse events subjected to compulsory reporting to State Institute for Drug Control, Department of Pharmacovigilance.
Keywords: acute dystonia, tardive dystonia, tardive dyskinesias, neuroleptic malignant syndrome, serotonin syndrome, withdrawalinduced syndrome, pharmacovigilance.
Published: October 2, 2023 Show citation
Češková E, Horská K. Serious states induced by taking psychopharmacs and their treatment. Pharmacy for Practice. 2023;19(3):e4-9.